Esophagitis overview

Revision as of 21:41, 29 July 2020 by WikiBot (talk | contribs) (Bot: Removing from Primary care)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Esophagitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Esophagitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Esophagitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Esophagitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Esophagitis overview

CDC on Esophagitis overview

Esophagitis overview in the news

Blogs on Esophagitis overview

Directions to Hospitals Treating Esophagitis

Risk calculators and risk factors for Esophagitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ajay Gade MD[2]] ; Aditya Ganti M.B.B.S. [3]

Overview

The esophagus is a part of the gastrointestinal tract which is responsible of moving the food from the mouth to the rectum. Esophagitis is a general term for any inflammation, irritation, or swelling of the esophagus. The inflammation can be due to a variety of causes such as gastroesophageal reflux disease, viruses, or chemical injuries. Basing on the etiology and severity of disease, esophagitis into 4 types ( eosinophilic esophagitis, infectious esophagitis, pill induced esophagitis, and reflux esophagitis) and 4 grades (grade 1, grade 2, grade 3, and grade4) respectively. When ever esophagus gets irritated whether due to acid reflux or any other disease process inflammation sets in. If left untreated, chronic inflammation can lead to metaplasia of lower esophagus and ultimately leading to carcinoma of esopahgus. The most common symptoms of the esophagitis include halitosis, epigastric chest pain, often radiating to the back, dysphagia, odynophagia, hoarseness, oral ulcers and must be differentiated from other diseases such as peptic ulcer disease, acute coronary syndrome, angina pectoris, cholecystitis, biliary colic, pulmonary embolism and esophageal perforation. Prognosis of esophagitis is generally good with appropriate treatment. Diagnosis of esophagitis is mostly clinical. The mainstay of therapy for reflux esophagitis is acid suppression therapy. Patients with infectious esophagitis are treated with antimicrobial therapy, whereas patients with eosinophilic esophagitis are treated with corticosteroids.

Historical Perspective

GERD is believed to be first described and treated by the ancient Egyptians according to the papyrus which was discovered by Edwin Smith at Thebes. The esophagus itself was named by the ancient Greeks. Friedenwald, and Feldman described the symptoms of GERD in 1925. Robbins and Jankelson used the radiological procedures to observe GERD in 1926. In 1981, Picus and Frank reported a case of a 16-year-old boy with progressive dysphagia for 1.5 years, endoscopic findings were suggestive of multiple 1-mm nodular filling defects in the esophagus in an area of stricture with dilatation above. The radiology showed a luminal narrowing, wall rigidity, and high circulating eosinophil count assumed to be a variant of eosinophilic gastroenteritis.

Classification

Esophagitis may be classified according to the Los Angeles Classification into 4 grades.

Pathophysiology

The esophagus is a part of the gastrointestinal tract which is responsible of moving the food from the mouth to the rectum. Esophagitis is defined as inflammation of mucosal layer of esophagus. Based on the etiology of inflammation esophagitis can be classified into reflux esophagitis and eosinophilic esophagitis. Any condition that lead to the reflux of the gastric acidic contents into the esophagus results in reflux esophagitis. Eosinophilic esophagitis is an immunoallergic disorder resulting from the interaction between genetics and environmental triggers such as repeated exposure to food and aeroallergens. TH2 inflammatory cell response play a major role in the production of eosinophils. Activated TH2 response leads to the recruitment and activation of eosinophils and mast cells. Characteristic gross pathology findings of esophagitis include fixed esophageal ring, white exudates, longitudinal furrows/ fibrosis, mucosal pallor, Diffuse esophageal narrowing. Characteristic microscopic findings of esophagitis include edema and basal hyperplasia (non-specific inflammatory changes), lymphocytic infiltration, neutrophilic infiltration, eosinophilic infiltration, goblet cell intestinal metaplasia or Barrett's esophagus and elongation of the papillae.

Causes

Common causes of esophagitis include gastroesophageal reflux disease, Barrett's esophagus, caustic burns, and chemical injury by either alkaline or acid solutions. Among immuncompromised patients, the most common causes of esophagitis are Candidiasis, Cytomegalovirus, and Herpes simplex virus

Differentiating Esophagitis overview from Other Diseases

Esophagitis must be differentiated from gastritis, peptic ulcer disease, gastroesophageal reflux disease, acute coronary syndrome, angina pectoris, cholecystitis, biliary colic, pulmonary embolism and esophageal perforation, rupture and tears.

Epidemiology and Demographics

In the USA and Europe, the prevalence of GERD ranges from low of 10,000 per 100,000 persons to high of 20,000 per 100,000 people. In Asia, the prevalence of GERD is 5,000 per 100,000 people. The prevalence of EoE is approximately 50-100 per 100,000 individuals worldwide. In the USA, the incidence of GERD is 5,400 per 100,000 persons. In Europe, the incidence of GERD is 840 per 100,000 persons. The incidence of EoE is approximately 10 per 100,000 individuals worldwide. The prevalence of GERD increases with age. GERD affects all age groups but it affects more the people older than 40 years. Patients of all age groups may develop EoE. Men and women are affected equally by GERD. Males are more commonly affected by EoE than females. There is no racial predilection for GERD. EoE usually affects individuals of the white race.

Risk Factors

Common risk factors in the development of esophagitis are immunosuppression, alcohol use, smoking, excessive vomiting, certain medications, and surgery or radiation to the chest.

Screening

There is insufficient evidence to recommend routine screening for Esophagitis.

Natural History, Complications, and Prognosis

If left untreated, 20% of patients with esophagitis may progress to develop esophageal stricture due to excessive acid in the lower esophagus. Common complications of esophagitis include esophageal ulcer, and esophageal adenocarcinoma. Prognosis of esophagitis is generally good with appropriate treatment.

Diagnosis

Diagnostic Criteria

History and Symptoms

The most common symptoms of the esophagitis include halitosis, epigastric chest pain, often radiating to the back, dysphagia, odynophagia, hoarseness, oral ulcers.

Physical Examination

The physical examination usually is not helpful in confirming the diagnosis of uncomplicated esophagitis. However, the examination may reveal other potential sources of chest or abdominal pain.

Laboratory Findings

A complete blood count (CBC) is performed in patients with neutropenia or who are immunosuppressed. A CD4 count and HIV test are performed in patients with risk factors for HIV. A collagen workup (eg, antinuclear antibody [ANA], anti-dsDNA) may be performed based on the underlying disease.

Electrocardiogram Findings

There are no specific electrocardiogram findings associated with esophagitis.

X-ray

Barium studies cannot diagnose esophagitis but are helpful in identifying any underlying anatomical abnormalities such as strictures or rings.

Echocardiogram/ultrasound findings

There are no echocardiography/ultrasound findings associated with esophagitis.

CT

There are no CT scan findings associated with esophagitis. However, a CT scan may be helpful in the diagnosis of complications of esophagitis such as tearsperforationstrictures, etc.

MRI

There are no MRI findings associated with esophagitis. however, MRI may be helpful in the diagnosis of complications of esophagitis such as tearsperforationstrictures, etc.

Imaging Findings

There are no other imaging findings associated with esophagitis.

Other Diagnostic Studies

The endoscope has been before one of the diagnostic tools for esophagitis. However, endoscopy is not recommended now for the diagnosis of esophagitis with the typical symptoms, however, it is used in screening for the esophagitis complications such as esophageal strictures, and barrett's esophagus

Treatment

Medical Therapy

The mainstay of therapy for reflux esophagitis is acid suppression therapy. Patients with infectious esophagitis are treated with antimicrobial therapy, whereas patients with eosinophilic esophagitis are treated with corticosteroids. Supportive therapy for esophagitis includes proton pump inhibitors, topical pain medications (gargled or swallowed), smoking and alcohol cessation, and endoscopy to remove any lodged pill fragments.

Surgery

Surgical intervention is not recommended for the management of esophagitis. However, esophageal dilation can be employed in cases of severe dysphagianot responding to medial therapy.

Primary prevention

Effective primary preventive measures for esophagitis include weight loss, having head elevated while sleeping, and avoidance of certain foods that can trigger inflammation of esophagus.

Secondary prevention

There are no established measures for the secondary prevention of esophagitis.

References

Template:WH Template:WS